James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

The Apple Watch Won’t Make or Break AAPL Stock, But…

The Apple Watch has admittedly been "meh", but owners of AAPL stock need to look at it through a longer-term lens.

Why bluebird bio Inc. (BLUE), Valeant Pharmaceuticals Intl Inc (VRX) and QUALCOMM, Inc. (QCOM) Are 3 of Today’s Worst Stocks

The market couldn't shed bluebird bio (BLUE), Valeant Pharmaceuticals (VRX) and QUALCOMM (QCOM) fast enough on Thursday.

FB Stock Vs. TWTR Stock, Redux

FB stock may be overbought and TWTR stock may be oversold, but that's no reason to expect a role reversal anytime soon.

Live Broadcasts Add Nothing to the Value of Netflix Stock

Owners of Netflix stock should be glad live sports and live news aren't part of the mix, but not for the reasons Reed Hastings has given.

Why Groupon Inc (GRPN), Motorola Solutions Inc (MSI) and Time Warner Inc (TWX) Are 3 of Today’s Worst Stocks

Hump-day was more than forgettable for Groupon (GRPN), Motorola Solutions (MSI) and Time Warner (TWX). Here's why each blew up.